From 30/04 Update "Cash receipts for Q3 were $258,647, which...

From 30/04 Update

"Cash receipts for Q3 were $258,647, which does not include sales from Priceline
Pharmacies, Little Innoscents, the balance of the payment from sales in India and sales
across the Ayingdao Mum and Baby stores in China as these are to be received in the
coming second quarter 2018"

Cash receipts should be up from the deferred payments from API. I anticipate sales would be flat though. From my observation on the ground, I don't see API or Metcash topping up from the initial orders. Be on the ball on 31/06/18 to put in those buy/sell orders.